Turnstone Biologics Corp. (TSBX) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 40 transactions totaling $15.4M, demonstrating a bullish sentiment with $15.4M in net insider flow. The most recent transaction on Aug 8, 2025 involved a transaction of 3,099,265 shares valued at $0.
No significant insider buying has been recorded for TSBX in the recent period.
No significant insider selling has been recorded for TSBX in the recent period.
Based on recent SEC filings, insider sentiment for TSBX is bullish with an Insider Alignment Score of 100/100 and a net flow of $15.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Turnstone Biologics Corp. (TSBX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading TSBX stock, having executed 40 transactions in the past 90 days. The most active insider is Rishi Gupta (Executive), who has made 3 transactions totaling $5.0M.
Get notified when executives and directors at TSBX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | Gupta Rishi | Executive | Tender | 3,099,265 | $N/A | $0 | |
| Aug 8, 2025 | Jerel Davis | Executive | Tender | 90,888 | $N/A | $0 | |
| Aug 8, 2025 | Jerel Davis | Executive | Tender | 2,726,322 | $N/A | $0 | |
| Aug 8, 2025 | Jerel Davis | Executive | Tender | 274,990 | $N/A | $0 | |
| Aug 8, 2025 | Jerel Davis | Executive | Tender | 82,006 | $N/A | $0 | |
| Aug 8, 2025 | Jerel Davis | Executive | Tender | 207,486 | $N/A | $0 | |
| Aug 8, 2025 | Capital V, L.p. Versant Venture | Executive | Tender | 2,726,322 | $N/A | $0 | |
| Aug 8, 2025 | Capital V, L.p. Versant Venture | Executive | Tender | 207,486 | $N/A | $0 | |
| Aug 8, 2025 | Capital V, L.p. Versant Venture | Executive | Tender | 90,888 | $N/A | $0 | |
| Aug 8, 2025 | Capital V, L.p. Versant Venture | Executive | Tender | 274,990 | $N/A | $0 | |
| Aug 8, 2025 | Capital V, L.p. Versant Venture | Executive | Tender | 82,006 | $N/A | $0 | |
| Aug 8, 2025 | Llc Orbimed Advisors | Executive | Tender | 3,099,265 | $N/A | $0 | |
| Jul 25, 2023 | Fmr Llc | Executive | Conversion | 4,939 | $N/A | $0 | |
| Jul 25, 2023 | Fmr Llc | Executive | Conversion | 296,396 | $N/A | $0 | |
| Jul 25, 2023 | Fmr Llc | Executive | Conversion | 483,684 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 10 | $15.4M | 100.0% |
Tender(U) | 12 | $0 | 0.0% |
Conversion(C) | 18 | $0 | 0.0% |
Insiders at Turnstone Biologics Corp. are accumulating shares at an accelerated pace. With 5 insiders making 40 transactions totaling $15.4M in purchases versus $0 in sales, the net buying activity of $15.4M signals strong executive confidence. Rishi Gupta (Executive) leads the buying activity with $5.0M in transactions across all time.